Clinical Trials on Protein Digestion & Absorption in Australia

Total 2117 results

RDC Clinical Pty Ltd

Completed

A Study to Determine Optimal Absorption of Single Dose Omega-3

Optimal Gastrointestinal Absorption of Omega-3

Australia
FertilitySA
University of Adelaide

Completed

EmbryoGen/ Blastgen for Couples With Implantation Problems or Previous Miscarriage (BlastGen)

Infertility | Recurrent Miscarriage

Australia
Mondelēz International, Inc.
University of Sydney

Completed

Determination of the Postprandial Responses to Two Cereal Foods Differing by Their SDS Content Consumed Alone.

Metabolic Disorder; Carbohydrate, Absorption, Intestine

Australia
The Canberra Hospital

Completed

Intravenous Saline Pre-hydration in Patients Undergoing Outpatient Colonoscopy

Colonic Diseases

Australia
Karolinska Institutet
Ullevaal University Hospital; University of Helsinki; Gynmed Clinic Vienna

Completed

Routine Follow-up Versus Self-assessment in Medical Abortion

Medical Abortion

Sweden, Austria, Finland, Norway
Abbott Products

Completed

Habitual Abortion Study: Oral Dydrogesterone Treatment During Pregnancy in Women With Recurrent Miscarriage

Recurrent Miscarriage

Austria, Poland
Celgene Corporation

Completed

A Multicentre, Single-arm, Open-label Safety Study of Lenalidomide Plus Dexamethasone in Previously Treated Subjects With Multiple Myeloma

Multiple Myeloma

Ireland, Spain, Australia, Austria, United Kingdom
University of Jena

Completed

Effectiveness of Dalteparin Therapy as Intervention in Recurrent Pregnancy Loss

Abortion, Habitual

Germany, Austria
Monash University

Recruiting

Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy: Immunoglobulin Stopping or Extension (RATIONALISE)

Hypogammaglobulinemia | Haematological Malignancy

Australia
Oslo University Hospital
St John of God Hospital, Vienna; Nepean Blue Mountains Local Health District

Completed

Bowel ENDOmetriosis; Evaluation of Diagnostics and Quality of Life (ENDO)

Quality of Life | Pain, Chronic | Deep Endometriosis | Bowel Dysfunction | Endometriosis Related Pain | Endometriosis Rectum | Deep Infiltrating Endometriosis

Norway, Australia, Austria
Celgene

Completed

NPI-0052 and Vorinostat in Patients With Non-small Cell Lung Cancer, Pancreatic Cancer, Melanoma or Lymphoma

Melanoma | Lymphoma | Multiple Myeloma | Pancreatic Cancer | Non-Small Cell Lung Cancer

Australia
Medical University of Vienna
Vifor Pharma, Inc.

Recruiting

Iron Status in Female Infertility and Recurrent Miscarriage

Infertility | Iron-deficiency | Recurrent Miscarriage

Austria
Niels Jørgen Secher

Terminated

Cervical Occlusion for the Prevention of Preterm Birth

Uterine Cervical Incompetence

United Kingdom, India, Australia, South Africa, Denmark, Saudi Arabia, Spain, Sweden, Switzerland
Kirby Institute

Not yet recruiting

The National Australian HCV Point-of-Care Testing Program - HCV Antibody Testing Minimal Dataset

Hepatitis C

Australia
Bayside Health

Terminated

Study of Azacitidine to Treat Relapsed or Refractory Multiple Myeloma

Multiple Myeloma

Australia
Peter MacCallum Cancer Centre, Australia
Melbourne Health

Completed

NMP in Relapsed / Refractory Myeloma

Multiple Myeloma

Australia
Peter MacCallum Cancer Centre, Australia
Celgene Corporation

Unknown

A Study of Low Dose Lenalidomide and Dexamethasone in Relapsed/Refractory Myeloma in Patients at High Risk for Myelosuppression

Multiple Myeloma

Australia
GlaxoSmithKline

Withdrawn

A Study of GSK2110183 in Subjects With Proteasome Inhibitor Refractory Multiple Myeloma

Cancer

Australia
Peter MacCallum Cancer Centre, Australia
Celgene Corporation; Janssen-Cilag Ltd.

Unknown

A Phase I/II Trial of Romidepsin (Depsipeptide) and Bortezomib in Patients With Relapsed Myeloma

Multiple Myeloma

Australia
Genentech, Inc.

Recruiting

A Study to Evaluate the Safety and Pharmacokinetics of XMAB24306 in Combination With Daratumumab in Participants With Relapsed/Refractory Multiple Myeloma

Multiple Myeloma

Spain, Australia, Denmark, Norway
Bayside Health

Unknown

Atorvastatin in Myeloma

Myeloma

Australia
Ichnos Sciences SA

Not yet recruiting

Study of ISB 2001 in Relapsed/Refractory Multiple Myeloma

Relapsed/Refractory Multiple Myeloma

Australia
Peter MacCallum Cancer Centre, Australia
The Leukemia and Lymphoma Society

Completed

A Study of Peripheral Blood Progenitor Cells Mobilisation (PBPC) With VTP195183 Plus Granulocyte-Colony Stimulating Factor (G-CSF) Compared to Mobilisation With G-CSF Alone

Lymphoma | Multiple Myeloma

Australia
Peter MacCallum Cancer Centre, Australia
Janssen, LP

Recruiting

CAR-T Cell Therapy in RelApsed/Refractory Myeloma With ExtrameduLlary Disease - an in Vivo Imaging and Molecular Monitoring Study (CARAMEL)

Extramedullary Myeloma

Australia
EBG MedAustron GmbH
Landesklinkum Wiener Neustadt

Recruiting

Preoperative, Proton- Radiotherapy Combined With Chemotherapy for Borderline Resectable Pancreatic Cancer (PARC)

Pancreatic Cancer | Proton Therapy

Austria
AbbVie

Withdrawn

A Study of Venetoclax and ABBV-838 Combination Therapy With Dexamethasone in Participants With Multiple Myeloma Whose Cancer Has Come Back or Had No Response to Recent Cancer Treatment

Multiple Myeloma

Australia
Life Molecular Imaging SA

Completed

Florbetaben (BAY94-9172) PET (Positron Emission Tomography) Imaging in MCI (Mild Cognitive Impairment) Patients

Alzheimer Disease | Amyloid Beta-Protein

Australia
Cancer Trials Australia
Human Genome Sciences Inc.

Unknown

A Study of Belimumab in Treating Symptomatic Waldenstroms Macroglobulinaemia

Symptomatic Waldenstroms Macroglobulinaemia

Australia
Gilead Sciences

Terminated

Efficacy Study of CYT997 in Multiple Myeloma

Relapsed and Refractory Multiple Myeloma

Australia
Bayer

Terminated

Multiple Escalating Dose Study of BAY1093884 in Adults With Hemophilia A or B With or Without Inhibitors

Hemophilia A and B

Australia, United Kingdom, Taiwan, Japan, Korea, Republic of, Austria, Bulgaria, Hungary, Italy, France, New Zealand
Hoffmann-La Roche

Completed

A Translational Study of Bevacizumab in Participants With Metastatic Colorectal Cancer (ASCENT)

Colorectal Neoplasms

Australia
Peter MacCallum Cancer Centre, Australia
Janssen-Cilag Ltd.

Completed

Bortezomib and Dexamethasone as Treatment and Maintenance for Multiple Myeloma Relapse

Multiple Myeloma

Australia
Carina Biotech Limited

Recruiting

A Study of CNA3103 (LGR5-targeted, Autologous CAR-T Cells) Administered to Subjects With Metastatic Colorectal Cancer

Colorectal Cancer Metastatic

Australia
Innovent Biologics (Suzhou) Co. Ltd.

Not yet recruiting

A Study of IBI3003 in Subjects With Relapsed or Refractory Multiple Myeloma

Multiple Myeloma

Australia
Zeria Pharmaceutical

Completed

The Effects of Z-338 in Subjects With and Without Functional Dyspepsia

Dyspepsia

Australia
The Queen Elizabeth Hospital
Novartis; Amgen

Completed

Safety Study of the Combination of Panitumumab, Irinotecan and Everolimus in the Treatment of Advanced Colorectal Cancer (PIE)

Colorectal Cancer | Colorectal Tumors | Colorectal Carcinoma | Neoplasms, Colorectal

Australia
Academisch Medisch Centrum - Universiteit van Amsterdam...

Unknown

The Dynamic Interplay Between Bleeding Phenotype and Baseline Factor Level in Moderate and Mild Hemophilia A and B (DYNAMO)

Hemophilia

Netherlands, Austria, Australia, Belgium, Canada, Finland, Germany, Italy, Spain, United Kingdom
Peter MacCallum Cancer Centre, Australia

Completed

Panobinostat Biological Correlates Study (VEG VCA1)

Multiple Myeloma | Nodal Lymphoma | Lymphoma With Cutaneous Involvement | Lymphoma in Leukemic Phase | Marrow Involvement With Lymphoma

Australia
Hemay Pharmaceutical PTY. LTD.
Tianjin Hemay Pharmaceutical Co., Ltd

Unknown

PhaseⅠFirst-in-Human Study of Hemay007 in Healthy Volunteers

Inflammatory Bowel Disease

Australia
Novartis Pharmaceuticals

Completed

Long Term Efficacy and Safety of Zoledronic Acid Treatment in Patients With Bone Metastases

Bone Neoplasms

Australia
Atridia Pty Ltd.

Completed

A Trial of HRS-7085 Tablet in Healthy Participants With and Without Food Effect.

Inflammatory Bowel Disease

Australia
Lisata Therapeutics, Inc.

Completed

CEND-1 in Combination With Nabpaclitaxel and Gemcitabine in Metastatic Pancreatic Cancer

Pancreatic Cancer | Pancreatic Ductal Adenocarcinoma

Australia
R.P.Herrmann
The Alfred; The Queen Elizabeth Hospital; Concord Hospital; Sir Charles Gairdner...

Completed

An Australian Study of Mesenchymal Stromal Cells for Crohn's Disease

Crohn Disease

Australia
Orphan Australia

Completed

VSL#3 Versus Placebo in Maintenance of Remission in Crohn's Disease

Crohn's Disease

Australia
Peter MacCallum Cancer Centre, Australia
The Leukemia and Lymphoma Society

Completed

ATRA Plus G-CSF for Mobilization of Hematopoietic Stem and Progenitor Cells

Multiple Myeloma | Cutaneous Lymphoma

Australia
Inipharm Australia Pty Ltd

Recruiting

A Study of INI-822 in Healthy Volunteers and Participants With Non-alcoholic Steatohepatitis (NASH) or Presumed NASH

Non-alcoholic Steatohepatitis

Australia
Associate Professor Helen Marshall
Merck Sharp & Dohme LLC

Unknown

Impact of Rotavirus Vaccine Introduction for South Australian Children

Gastroenteritis | Viral Gastroenteritis Due to Rotavirus

Australia
Royal Perth Hospital

Recruiting

Image Enhanced Endoscopy IBD

Inflammatory Bowel Diseases | Dysplasia

Australia
Shanghai EpimAb Biotherapeutics Co., Ltd.

Recruiting

A Ph1/2 Study of EMB-06 in Participants With Relapsed or Refractory Myeloma

Relapsed or Refractory Multiple Myeloma

China, Australia
GlaxoSmithKline

Completed

A Phase 1, Randomized, Placebo-Controlled, Ascending Cohort, Dose Escalation Study in Normal Healthy Volunteers

Irritable Bowel Syndrome

Australia

Clinical Trials on Protein Digestion & Absorption in Australia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mali

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations